Biochemistry, Genetics and Molecular Biology
Allele
39%
Artificial Intelligence
11%
Binding Site
22%
Bioinformatics
12%
BRCA1
28%
BRCA2
16%
Cancer Cell
13%
Cancer Immunotherapy
11%
Case-Control Study
14%
Clopidogrel
44%
CpG Site
11%
Decitabine
13%
Dideoxynucleotide Sequencing
13%
Electrophoretic Mobility Shift Assay
22%
Exome Sequencing
64%
Gene Control
11%
Gene Expression
19%
Gene Frequency
31%
Genetic Determinism
27%
Genetic Divergence
23%
Genetic Risk
25%
Genetic Variation
14%
Genetics
69%
Genomics
49%
Genotyping
13%
Germ Cell
25%
Germline
25%
Human Papillomavirus Type 16
33%
Luciferase
30%
Lymphoid Enhancer-Binding Factor 1
11%
Melting Point
11%
Metabolic Pathway
14%
Methylation
15%
MicroRNA
20%
Missense
19%
Missense Mutation
11%
Next Generation Sequencing
100%
Pharmacogenetic Testing
39%
Pharmacogenetic Variant
13%
Pharmacogenomics
15%
Platelet Reactivity
44%
Population Genetics
12%
Promoter Region
13%
Rare Variant
16%
Reporter Gene
30%
SARS Coronavirus
17%
Single-Nucleotide Polymorphism
14%
T Cell
22%
TCF3
11%
Transcription Factor
33%
Keyphrases
5-aza-2′-deoxycytidine
14%
Adverse Drug Reaction
19%
Allele Frequency
20%
Breast Cancer
33%
Breast Cancer Susceptibility Gene 1 (BRCA1)
19%
Cervical Cancer
15%
Clinical Practice
14%
Clopidogrel
35%
Closure Time
18%
Colombia
23%
Colombian Patients
19%
Colombians
72%
Colorectal Cancer
34%
COVID-19
35%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
28%
Etiology
14%
Functional Analysis
22%
Functional Impact
17%
Functional Validation
15%
Genetic Profile
26%
Genetic Risk
20%
Genetic Variants
16%
Genotype
14%
HELLP Syndrome
22%
High On-treatment Platelet Reactivity
33%
High-risk Human Papillomavirus (HR-HPV)
24%
HPV16
25%
HPV16 E7
22%
Human Papillomavirus Testing
14%
Inter-individual Variability
18%
Mayors
31%
Methylation
14%
MicroRNA
22%
Molecular Diagnostics
14%
Molecular Variants
17%
New Risks
22%
Next-generation Sequencing
82%
Non-genetic Factors
16%
Pathogenic Variants
28%
Pharmacogenetic Variants
13%
Pharmacogenomics
17%
Pharmacological Analysis
33%
Platelet Reactivity
44%
Polymorphism
22%
Preeclampsia
30%
Rare Variants
18%
Single nucleotide Polymorphism
18%
STOX1
14%
TFL1
12%
Whole Exome Sequencing
37%
